摘要: The indolent B-cell lymphomas account for about one third of all in the Western world. follicular are largest and most easily recognized category lymphoma, representing quarter world.1, 2, 3 incidence lymphoma is markedly lower Asia than West, unclear reasons.4 Other well-defined (and their approximate percentage incidence) are: small lymphocytic (6%); nodal marginal zone (1–2%); extranodal mucosa-associated lymphoid tissue, or MALT (5–7%); splenic variant with villous lymphocytes (< 1%); lymphoplasmacytic (1%).
springer.com
sci-hub.st 参考文章(145)
SJ Korsmeyer, Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood. ,vol. 80, pp. 879- 886 ,(1992) , 10.1182/BLOOD.V80.4.879.BLOODJOURNAL804879
Young Rc, DeVita Vt, Glatstein E, Jaffe Es, Longo Dl, Ihde Dc, The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Seminars in Hematology. ,vol. 25, pp. 11- 16 ,(1988)
JG Gribben, D Neuberg, M Barber, J Moore, KW Pesek, AS Freedman, LM Nadler, Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow Blood. ,vol. 83, pp. 3800- 3807 ,(1994) , 10.1182/BLOOD.V83.12.3800.3800
G Pozzato, C Mazzaro, M Crovatto, ML Modolo, S Ceselli, G Mazzi, S Sulfaro, F Franzin, P Tulissi, M Moretti, Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. ,vol. 84, pp. 3047- 3053 ,(1994) , 10.1182/BLOOD.V84.9.3047.3047
Armando López-Guillermo, Fernando Cabanillas, Peter McLaughlin, Terry Smith, Fredrick Hagemeister, Marı́a A. Rodrı́guez, Jorge E. Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, William Pugh, Ming-Seng Lee, The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas Blood. ,vol. 91, pp. 2955- 2960 ,(1998) , 10.1182/BLOOD.V91.8.2955.2955_2955_2960
F Berger, P Felman, A Sonet, G Salles, Y Bastion, PA Bryon, B Coiffier, Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome Blood. ,vol. 83, pp. 2829- 2835 ,(1994) , 10.1182/BLOOD.V83.10.2829.2829
M. Eck, B. Schmaußer, A. Greiner, H. K. Müller-Hermelink, Helicobacter pylori in Gastric Mucosa-Associated Lymphoid Tissue Type Lymphoma Gastrointestinal Lymphoma. ,vol. 156, pp. 9- 18 ,(2000) , 10.1007/978-3-642-57054-4_2
Armando López-Guillermo, Fernando Cabanillas, Timothy I. McDonnell, Peter McLaughlin, Terry Smith, William Pugh, Fredrick Hagemeister, M. Alma Rodrı́guez, Jorge E. Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, Ming-Seng Lee, Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood. ,vol. 93, pp. 3081- 3087 ,(1999) , 10.1182/BLOOD.V93.9.3081
David G. Maloney, Antonio J. Grillo-López, Christine A. White, David Bodkin, Russell J. Schilder, James A. Neidhart, Nalini Janakiraman, Kenneth A. Foon, Tina-Marie Liles, Brian K. Dallaire, Ken Wey, Ivor Royston, Thomas Davis, Ronald Levy, IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma Blood. ,vol. 90, pp. 2188- 2195 ,(1997) , 10.1182/BLOOD.V90.6.2188
Wolfgang Fischbach, Gastrointestinal Lymphoma: Future Perspectives ,(2012)